Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cotrimoxazole Prophylaxis Cessation in Stabilized HIV Patients
NCT00674921Phase 4Unknown
- Sponsor
- MRC/UVRI and LSHTM Uganda Research Unit
- Start
- Jun 2008
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of trimethoprim + sulfamethoxazole in pneumonia and malaria (4 arms), sponsored by MRC/UVRI and LSHTM Uganda Research Unit. Primary endpoint: All-cause morbidity such as pneumonia or malaria at 3 years. Status: unknown.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
pneumoniamalaria
Beyond the preview
Go deeper on NCT00674921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00674921.